Reuters logo
BRIEF-Sarepta Therapeutics announces FDA request for dystrophin data
2016年6月6日 / 晚上9点52分 / 1 年前

BRIEF-Sarepta Therapeutics announces FDA request for dystrophin data

June 6 (Reuters) - Sarepta Therapeutics Inc

* Sarepta Therapeutics announces FDA request for dystrophin data prior to making a decision on eteplirsen NDA

* Sarepta Therapeutics announces FDA request for dystrophin data prior to making a decision on eteplirsen NDA

* Plans to submit data from thirteen patient biopsy samples, at baseline and week 48, to FDA over coming weeks Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below